{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T07:14:17Z","timestamp":1725866057383},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s10096-005-0081-z","type":"journal-article","created":{"date-parts":[[2006,1,12]],"date-time":"2006-01-12T07:16:56Z","timestamp":1137050216000},"page":"39-42","source":"Crossref","is-referenced-by-count":4,"title":["Bacteremic pneumococcal pneumonia associated with macrolide failure"],"prefix":"10.1007","volume":"25","author":[{"given":"J.","family":"Dylewski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,1,13]]},"reference":[{"key":"81_CR1","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1086\/341980","volume":"35","author":"MR Jacobs","year":"2002","unstructured":"Jacobs MR (2002) In vivo veritas: in vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure. Clin Infect Dis 35:565\u2013569","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"81_CR2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/382691","volume":"38","author":"CD Rothermel","year":"2004","unstructured":"Rothermel CD (2004) Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes? Clin Infect Dis 38(Suppl 4):346\u2013349","journal-title":"Clin Infect Dis"},{"key":"81_CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11908-004-0018-1","volume":"6","author":"JR Lonks","year":"2004","unstructured":"Lonks JR (2004) What is the clinical impact of macrolide resistance? Current Infect Dis Reports 6:7\u201312","journal-title":"Current Infect Dis Reports"},{"key":"81_CR4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1086\/380126","volume":"38","author":"E Nuermberger","year":"2004","unstructured":"Nuermberger E, Bishai WR (2004) The clinical significance of macrolide-resistant Streptococcus pneumoniae: it\u2019s all relative. Clin Infect Dis 38:99\u2013103","journal-title":"Clin Infect Dis"},{"key":"81_CR5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/313959","volume":"31","author":"LA Mandell","year":"2000","unstructured":"Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH (2000) Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Infectious Community-Acquired Pneumonia Working Group. Clin Infect Dis 31:383\u2013421","journal-title":"Clin Infect Dis"},{"key":"81_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","volume":"31","author":"JC Bartlett","year":"2000","unstructured":"Bartlett JC, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ (2000) Practice guidelines for the management of community acquired pneumonia in adults. Clin Infect Dis 31:347\u2013382","journal-title":"Clin Infect Dis"},{"key":"81_CR7","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1086\/380488","volume":"37","author":"LA Mandell","year":"2003","unstructured":"Mandell LA, Bartlett JC, Dowell SF, File TM Jr, Musher DM, Whitney C (2003) Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37:1405\u20131433","journal-title":"Clin Infect Dis"},{"key":"81_CR8","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1378\/chest.125.5.1888","volume":"125","author":"TM File","year":"2004","unstructured":"File TM, Garau J, Blasi F et al (2004) Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia. Chest 125:1888\u20131901","journal-title":"Chest"},{"key":"81_CR9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijantimicag.2004.03.008","volume":"24","author":"M Rzeseszutek","year":"2004","unstructured":"Rzeseszutek M, Wierzbowski A, Hoban DJ, Conly J, Bishai W, Zhanel GG (2004) A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae. Int J Antimicrob Agents 24:95\u2013104","journal-title":"Int J Antimicrob Agents"},{"key":"81_CR10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","volume":"35","author":"JR Lonks","year":"2002","unstructured":"Lonks JR, Garau J, Gomez L et al (2002) Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis 35:556\u2013564","journal-title":"Clin Infect Dis"},{"key":"81_CR11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jac\/dkg116","volume":"51","author":"D Kerkhoven Van","year":"2003","unstructured":"Van Kerkhoven D, Peetermans WE, Verbist L, Verhaegen J (2003) Breakthrough pneumococcal bacteremia in patients with clarithromycin or oral beta-lactams. J Antimicrob Chemother 51:691\u2013696","journal-title":"J Antimicrob Chemother"},{"key":"81_CR12","volume-title":"Approved standard M100 S14","author":"National Committee for Clinical Laboratory Standards","year":"2004","unstructured":"National Committee for Clinical Laboratory Standards (2004) Performance standards for antimicrobial susceptibility testing. Fourteenth informational supplement. Approved standard M100 S14. NCCLS, Wayne, PA"},{"key":"81_CR13","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1128\/AAC.40.11.2562","volume":"40","author":"J Sutcliffe","year":"1996","unstructured":"Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L (1996) Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40:2562\u20132566","journal-title":"Antimicrob Agents Chemother"},{"key":"81_CR14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3201\/eid1106.050222","volume":"11","author":"DJ Farrell","year":"2005","unstructured":"Farrell DJ, Jenkins SJ, Brown SD, Patel M, Lavin BS, Klugman KP (2005) Emergence and spread of Streptococcus pneumoniae with erm (B) and mef (A) resistance. Emerg Infect Dis 11:851\u2013858","journal-title":"Emerg Infect Dis"},{"key":"81_CR15","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1128\/AAC.48.9.3305-3311.2004","volume":"48","author":"J Powis","year":"2004","unstructured":"Powis J, McGeer A, Green K et al (2004) In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002. Antimicrob Agents Chemother 48:3305\u20133311","journal-title":"Antimicrob Agents Chemother"},{"key":"81_CR16","first-page":"147","volume":"45","author":"DJ Hoban","year":"1998","unstructured":"Hoban DJ, Wierzbowski AK, Nichol K et al (1998) Macrolide-resistant Streptococcus pneumoniae in Canada during 1998\u20131999: prevalence of mef (A) and erm (B) and susceptibilities to ketolides. Antimicrob Agents Chemother 45:147\u2013150","journal-title":"Antimicrob Agents Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-005-0081-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-005-0081-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-005-0081-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:30:20Z","timestamp":1559107820000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-005-0081-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["81"],"URL":"https:\/\/doi.org\/10.1007\/s10096-005-0081-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}